PharmaCyte Biotech Inc (PMCB)

[Edward]

Quote
"According to PMCB financials their 14.5% ownership is worth $1,572,193 which makes all of Austrianova worth only $11 million.

Not true. PMCB does the accounting for the investment in Austrianova on a cost basis, instead of using the equity accounting method, which adjusts for the real value of the investment.


When the equity method is used to account for ownership in a company, the investor records the initial investment in the stock at cost and that value is periodically adjusted to reflect the changes in value due to the investor's share in the company's income or losses.